Stockhead on MSN
Health check: CSL places $500m-plus bet on rare kidney and liver disease drug candidate
CSL will pay an upfront US$355 million ($515m) to co-develop an external drug candidate aimed at treating rare kidney and ...
When skeletonized human remains are the only evidence left behind, forensic anthropologists turn to the microscopic ...
A simple, inexpensive needle test that can catch cancer early in dogs and cats is being skipped far more often than veterinary guidelines recommend, according to a new survey of small-animal practices ...
Previous work has suggested that γδ T cells are critical players in immune responses to helminth infections, although their ...
What do people actually do in a university laboratory?From the perspective of a high school student, a laboratory is a ...
Although tumor protein p53 (TP53) mutations are among the most common lesions in epithelial cancers, how p53 loss drives ...
The high-throughput, IVDR-compliant NanoZoomer S360MD for the EU is appropriate for utilization in clinical laboratories and hospitals. Designed for in vitro diagnostic use, the technology enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results